Financial reports
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
23 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
16 Mar 22
Current reports
8-K
Termination of a Material Definitive Agreement
20 Mar 24
8-K
Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq
7 Mar 24
8-K
Departure of Directors or Certain Officers
27 Dec 23
8-K
Departure of Directors or Certain Officers
7 Dec 23
8-K
Departure of Directors or Certain Officers
5 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
17 Nov 23
8-K
Other Events
12 Oct 23
8-K
Entry into a Material Definitive Agreement
5 Oct 23
8-K
Cyteir Therapeutics Announces Discontinuation of CYT-0851 Development Program and Planned Liquidation and Dissolution
30 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 23
Registration and prospectus
15-12G
Securities registration termination
29 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 24
AW
Withdrawal of amendment
21 Mar 24
AW
Withdrawal of amendment
21 Mar 24
AW
Withdrawal of amendment
21 Mar 24
POS AM
Prospectus update (post-effective amendment)
18 Mar 24
POS AM
Prospectus update (post-effective amendment)
18 Mar 24
POS AM
Prospectus update (post-effective amendment)
18 Mar 24
Proxies
DEFM14A
Proxy related to merger
12 Oct 23
DEFA14A
Additional proxy soliciting materials
12 Oct 23
PREM14A
Preliminary proxy related to merger
2 Oct 23
DEFA14A
Additional proxy soliciting materials
30 Jun 23
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
Other
EFFECT
Notice of effectiveness
14 Mar 24
UPLOAD
Letter from SEC
4 May 23
CORRESP
Correspondence with SEC
2 May 23
UPLOAD
Letter from SEC
1 May 23
EFFECT
Notice of effectiveness
17 Aug 22
CORRESP
Correspondence with SEC
12 Aug 22
UPLOAD
Letter from SEC
11 Aug 22
EFFECT
Notice of effectiveness
18 Jun 21
CERT
Certification of approval for exchange listing
17 Jun 21
CORRESP
Correspondence with SEC
15 Jun 21
Ownership
4
Braden Michael Leonard
25 Mar 24
SC 13G/A
BML Investment Partners, L.P.
19 Mar 24
4
Braden Michael Leonard
19 Mar 24
3
Braden Michael Leonard
19 Mar 24
SC 13D/A
GAMCO INVESTORS, INC. ET AL
12 Mar 24
4
David G Gaiero
5 Mar 24
4
MARKUS MD RENSCHLER
5 Mar 24
4
Jean George
16 Feb 24
SC 13G/A
Lightstone Ventures II, L.P.
14 Feb 24
SC 13G/A
BAKER BROS. ADVISORS LP
14 Feb 24